Tonix Pharmaceuticals Holding TNXP Cash Flow Statement (2010-2026)

NASDAQ TNXP
$13.14 -0.23 (-1.72%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Tonix Pharmaceuticals Holding Quarterly Cash Flow Statement

Periods 62 quarters
Latest Jun 2026

Tonix Pharmaceuticals Holding reported cash from operations of -$42.24M and free cash flow of -$40.78M for the quarter ended Jun 2026, down 184.8% year over year. This cash flow statement covers 62 quarters of results from Dec 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-18.53M-29.55M-26.42M-23.14M-28.98M-31.68M-33.01M-29.00M-27.98M-26.68M-21.35M-77.31M-15.84M-22.76M-15.66M-27.35M-31.84M-46.94M-40.19M-41.10M
Share-based Compensation
25.78M2.30M66.44M2.81M2.77M2.72M8.24M2.36M2.08M2.04M9.75M1.15M1.04M0.89M0.88M1.42M1.92M1.79M2.13M2.28M
Deferred Taxes
Gains from Investment Securities
-7.00M0.85M
Asset Writedowns and Impairment
58.96M0.30M-0.10M-0.65M
Cash from Operations
-12.95M-22.45M-31.05M-21.17M-23.54M-22.30M-32.91M-23.37M-23.39M-22.34M-17.57M-9.92M-18.80M-14.63M-16.58M-14.83M-28.78M-39.65M-42.32M-42.24M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.30M0.13M0.21M0.20M0.07M
Amortization of Deferred Charges
Depreciation & Amortization (CF)Depreciation & Amortization
0.01M0.03M0.06M0.10M0.25M0.84M0.89M0.90M1.22M1.26M1.21M1.21M0.51M0.50M0.49M0.48M0.46M0.49M0.56M0.62M
Change in Working Capital
Change in Receivables
1.64M-1.30M-0.37M-0.99M1.19M2.79M2.55M2.99M
Change in Inventory
-1.29M-1.16M-1.25M-0.05M-0.27M0.13M-1.22M-0.36M-2.37M2.90M
Change in Account Payables
4.56M0.16M-3.11M1.55M-2.52M3.03M0.57M-1.15M1.02M-3.94M2.98M3.73M-6.36M0.58M-0.35M3.06M1.02M-0.74M1.53M-0.60M
Change in Accured Expenses
-0.73M2.90M-2.03M-0.28M1.31M2.21M-2.96M1.36M-1.05M4.43M-1.75M0.91M0.47M1.55M-2.95M3.36M1.25M10.08M-2.06M1.75M
Other Working Capital Changes
0.57M-1.74M2.17M2.21M-3.63M-0.59M1.21M-1.47M-3.07M1.76M1.35M-2.37M0.34M-2.94M0.62M-0.13M1.68M1.00M0.28M1.49M
Investing Activities
Capital Expenditures
7.75M25.62M20.22M14.44M8.82M4.67M3.80M1.84M1.81M0.44M0.11M0.01M0.00M0.01M0.53M0.96M1.87M3.74M-1.46M
Sales of Property, Plant and Equipment
0.01M
Acquisitions
22.17M
Change in Acquisitions & Divestments
Cash from Investing Activities
-7.75M-25.62M-20.22M-14.44M-8.82M-4.67M-3.80M-24.02M-0.82M-0.43M-0.11M-0.01M-0.00M-0.01M-2.54M-0.96M-1.02M-1.69M-0.59M
Financing Activities
Other financing activities
0.07M0.04M0.03M22.54M0.02M0.00M0.08M
Debt Issuance and Repayment
Long-Term Debt Issuances
Long-Term Debt Repayments
0.23M0.70M0.70M0.70M9.65M
Change in Capital Stock
Net Shares Issued and Repurchased
0.49M40.66M0.30M5.80M374.008.48M0.00M0.67M1.21M1.03M
Net Equity Issued and Repurchased
37.89M43.77M13.02M26.88M9.63M2.44M1.03M6.27M9.20M43.61M85.86M62.23M13.89M94.86M66.95M20.13M33.49M
Misc.
Cash from Financing Activities
37.96M43.77M13.06M72.18M-4.62M7.23M-11.50M1.03M6.27M40.71M-0.21M7.03M42.91M85.15M49.53M10.99M94.86M59.14M20.20M33.51M
Exchange Rate Effect
-0.01M-0.01M-0.03M-0.02M-0.02M-0.01M-0.04M-0.01M-0.01M-0.00M0.00M-0.02M0.02M-0.01M-0.00M-0.00M-0.01M0.01M-0.06M
Change in Cash
17.25M-4.31M-38.23M36.54M-37.00M-19.75M-48.25M-46.36M-17.94M17.93M-17.90M-2.89M24.08M70.55M32.94M-6.38M65.11M18.46M-23.80M-9.39M
Free Cash Flow
-20.70M-48.07M-51.26M-35.61M-32.35M-26.97M-36.71M-25.21M-25.20M-22.78M-17.68M-9.92M-18.81M-14.63M-16.59M-15.36M-29.74M-41.52M-46.06M-40.78M
Net Cash Flow
17.26M-4.30M-38.20M36.57M-36.98M-19.74M-48.21M-46.36M-17.93M17.94M-17.89M-2.89M24.09M70.52M32.95M-6.38M65.12M18.47M-23.80M-9.32M